Latest news with #ARB
IOL News
10 hours ago
- Health
- IOL News
Controversial Med-Lemon ad: ARB's ruling on graphic sneeze sparks debate
The Advertising Regulatory Board took a closer look at a Med-Lemon advertisement following complaints, but gave it the green light. Image: File A med-Lemon advertisement depicting a graphic sneeze with mucus flying over others has sparked two complaints to the Advertising Regulatory Board (ARB). However, the ARB concluded that while the ad teeters on the edge of being 'gross' and 'offensive,' it does not breach advertising standards. One complaint described the ad as 'very disgusting and disturbing to watch,' arguing that it fails to promote hygiene, especially in the wake of the Covid-19 pandemic, and is in poor taste. The second complaint was in a similar vein, with a member of the public who saw the TV advertisement being disgusted by the sneezing person's bodily fluids spraying all over people. The advertiser responded that they recognise the heightened sensitivity around respiratory illnesses, especially in the wake of the Covid-19 pandemic, but they assured that this was carefully considered in their approach. The advertiser stated that their primary objective with the campaign was to address a critical public health challenge: the significant impact of influenza in South Africa. While Covid-19 has been a focus, the advertiser stated that it is important to remember that influenza remains a serious threat. 'Flu paints a bleak picture,' it said. According to the advertiser, the exaggerated dramatisation of a sneeze and the personal and social chaos it creates was a deliberate creative choice. 'By vividly portraying the unpleasant consequences of delayed treatment via exaggerated dramatisation, we aim to make consumers realise the importance of acting at the very first sign of symptoms,' the advertising company explained. It said this approach, while bold, is reasonable and justifiable in an open and democratic society, as it directly promotes public health and is proportionate to the significant societal concern surrounding respiratory illnesses. In analysing the advertisement, the directorate of the ARB said it has no difficulty in concurring that the sneeze depicted in the advertisement is unpleasant to watch. 'Bodily fluids are a significant disgust trigger for the average consumer, and this commercial certainly hits the mark for many consumers. That being said, disgust felt on the part of a viewer does not necessarily mean that an advertisement is in and of itself offensive,' it said. The directorate noted that the purpose of this commercial, as outlined by the advertiser, is to prevent an outcome such as the unpleasant sneeze. It said it understands that the audience is supposed to be disgusted by the sneezing man. The commercial delivers the message, loud and clear, that going out in public with raging respiratory infection symptoms affects all those around us, it said. Get your news on the go, click here to join the Cape Argus News WhatsApp channel. Cape Argus
IOL News
24-07-2025
- Health
- IOL News
Advertising Regulatory Board clears Med-Lemon's controversial sneeze ad
The Advertising Regulatory Board took a closer look at a Med-Lemon advertisement following complaints, but gave it the green light. Image: Supplied The Advertising Regulatory Board (ARB) has found that although a Med-Lemon advertisement depicting a graphic sneeze with mucus flying all over other people skates the fine line between 'gross' and 'offensive,' it does not breach the advertising standards code. The advert had sparked two complaints before the Advertising Regulatory Board (ARB). One of the complaints stated that the ad was "very disgusting and disturbing to watch". "It doesn't promote hygiene and so soon after the Covid-19 pandemic, it's in really bad taste with no sense of promoting hygiene.' The second complaint was in a similar vein, with a member of the public who saw the TV advertisement being disgusted by the sneezing person's bodily fluids spraying over people. The advertiser responded that they recognise the heightened sensitivity around respiratory illnesses, especially in the wake of the Covid-19 pandemic, but they assured that this was carefully considered in their approach. The advertiser stated that their primary objective with this campaign was to address a critical public health challenge: the significant impact of influenza in South Africa. While Covid-19 has been a focus, the advertiser stated that it is important to remember that influenza remains a serious threat. 'Flu paints a bleak picture,' it said. According to the advertiser, the exaggerated dramatisation of a sneeze and the personal and social chaos it creates was a deliberate creative choice. 'By vividly portraying the unpleasant consequences of delayed treatment via exaggerated dramatisation, we aim to make consumers realise the importance of acting at the very first sign of symptoms,' the advertising company explained. It said this approach, while bold, is reasonable and justifiable in an open and democratic society, as it directly promotes public health and is proportionate to the significant societal concern surrounding respiratory illnesses. In analysing the advertisement, the directorate of the ARB said it has no difficulty in concurring that the sneeze depicted in the advertisement is unpleasant to watch. 'Bodily fluids are a significant disgust trigger for the average consumer, and this commercial certainly hits the mark for many consumers. That being said, disgust felt on the part of a viewer does not necessarily mean that an advertisement is in and of itself offensive,' it said. The directorate noted that the purpose of this commercial, as outlined by the advertiser, is to prevent an outcome such as the unpleasant sneeze. It said it understands that the audience is supposed to be disgusted by the sneezing man. The commercial delivers the message, loud and clear, that going out in public with raging respiratory infection symptoms affects all those around us, it said. Cape Times
IOL News
24-07-2025
- Health
- IOL News
Med-Lemon's snotty sneeze ad met the required standards, ruled the Advertising Regulatory Board
A snotty sneeze with mucus flying all over other people used in a med-lemon has not gone down well with some, who have laid complaints with the Advertising Regulatory Board (ARB) Image: Freeimages A Med-Lemon advertisement depicting a graphic sneeze with mucus flying all over other people has sparked two complaints before the Advertising Regulatory Board (ARB). However, the ARB found that although it skates the fine line between 'gross' and 'offensive,' it does not breach the advertising standards code. One of the complaints before the board stated: 'The ad is very disgusting and disturbing to watch. It doesn't promote hygiene and so soon after the Covid-19 pandemic, it's in really bad taste with no sense of promoting hygiene.' The second complaint was in a similar vein, with a member of the public who saw the TV advertisement being disgusted by the sneezing person's bodily fluids spraying all over people. The advertiser responded that they recognised the heightened sensitivity around respiratory illnesses, especially in the wake of the Covid-19 pandemic, but they assured that their approach was carefully considered. The advertiser stated that their primary objective ws to address a critical public health challenge: the significant impact of influenza in South Africa. While Covid-19 has been a focus, the advertiser stated that it is important to remember that influenza remains a serious threat. 'Flu paints a bleak picture,' it said. According to the advertiser, the exaggerated dramatisation of a sneeze and the personal and social chaos it created was a deliberate creative choice. 'By vividly portraying the unpleasant consequences of delayed treatment via exaggerated dramatisation, we aim to make consumers realise the importance of acting at the very first sign of symptoms,' the advertising company explained. It said this approach, while bold, is reasonable and justifiable in an open and democratic society, as it directly promoted public health and is proportionate to the significant societal concern surrounding respiratory illnesses. In analysing the advertisement, the directorate of the ARB said it has no difficulty in concurring that the sneeze depicted in the advertisement was unpleasant to watch. 'Bodily fluids are a significant disgust trigger for the average consumer, and this commercial certainly hits the mark for many consumers. That being said, disgust felt on the part of a viewer does not necessarily mean that an advertisement is in and of itself offensive,' it said. The directorate noted that the purpose of this commercial, as outlined by the advertiser, was to prevent an outcome such as the unpleasant sneeze. It said it understands that the audience was supposed to be disgusted by the sneezing man. The commercial delivers the message, loud and clear, that going out in public with raging respiratory infection symptoms affects all those around us, it said. [email protected]
IOL News
23-07-2025
- Health
- IOL News
Advertising Regulatory Board rules on Med-Lemon's graphic sneeze ad
The Advertising Regulatory Board took a closer look at a Med-Lemon advertisement following complaints, but gave it the green light. Image: Supplied A Med-Lemon advertisement depicting a graphic sneeze with mucus flying all over other people has sparked two complaints before the Advertising Regulatory Board (ARB), but the ARB found that although it skates the fine line between 'gross' and 'offensive,' it does not breach the advertising standards code. One of the complaints before the board stated: 'The ad is very disgusting and disturbing to watch. It doesn't promote hygiene and so soon after the Covid-19 pandemic, it's in really bad taste with no sense of promoting hygiene.' The second complaint was in a similar vein, with a member of the public who saw the TV advertisement being disgusted by the sneezing person's bodily fluids spraying all over people. The advertiser responded that they recognise the heightened sensitivity around respiratory illnesses, especially in the wake of the Covid-19 pandemic, but they assured that this was carefully considered in their approach. The advertiser stated that their primary objective with this campaign is to address a critical public health challenge: the significant impact of influenza in South Africa. While Covid-19 has been a focus, the advertiser stated that it is important to remember that influenza remains a serious threat. 'Flu paints a bleak picture,' it said. According to the advertiser, the exaggerated dramatisation of a sneeze and the personal and social chaos it creates was a deliberate creative choice. 'By vividly portraying the unpleasant consequences of delayed treatment via exaggerated dramatisation, we aim to make consumers realise the importance of acting at the very first sign of symptoms,' the advertising company explained. It said this approach, while bold, is reasonable and justifiable in an open and democratic society, as it directly promotes public health and is proportionate to the significant societal concern surrounding respiratory illnesses. In analysing the advertisement, the directorate of the ARB said it has no difficulty in concurring that the sneeze depicted in the advertisement is unpleasant to watch. 'Bodily fluids are a significant disgust trigger for the average consumer, and this commercial certainly hits the mark for many consumers. That being said, disgust felt on the part of a viewer does not necessarily mean that an advertisement is in and of itself offensive,' it said. The directorate noted that the purpose of this commercial, as outlined by the advertiser, is to prevent an outcome such as the unpleasant sneeze. It said it understands that the audience is supposed to be disgusted by the sneezing man. The commercial delivers the message, loud and clear, that going out in public with raging respiratory infection symptoms affects all those around us, it said. [email protected]
Yahoo
23-07-2025
- Business
- Yahoo
Return Trends At ARB (ASX:ARB) Aren't Appealing
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. With that in mind, the ROCE of ARB (ASX:ARB) looks decent, right now, so lets see what the trend of returns can tell us. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Return On Capital Employed (ROCE): What Is It? For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for ARB, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.18 = AU$144m ÷ (AU$881m - AU$101m) (Based on the trailing twelve months to December 2024). So, ARB has an ROCE of 18%. On its own, that's a standard return, however it's much better than the 11% generated by the Auto Components industry. See our latest analysis for ARB In the above chart we have measured ARB's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for ARB . How Are Returns Trending? While the current returns on capital are decent, they haven't changed much. The company has consistently earned 18% for the last five years, and the capital employed within the business has risen 94% in that time. Since 18% is a moderate ROCE though, it's good to see a business can continue to reinvest at these decent rates of return. Stable returns in this ballpark can be unexciting, but if they can be maintained over the long run, they often provide nice rewards to shareholders. Our Take On ARB's ROCE In the end, ARB has proven its ability to adequately reinvest capital at good rates of return. Therefore it's no surprise that shareholders have earned a respectable 89% return if they held over the last five years. So while the positive underlying trends may be accounted for by investors, we still think this stock is worth looking into further. While ARB doesn't shine too bright in this respect, it's still worth seeing if the company is trading at attractive prices. You can find that out with our on our platform. If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
